SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001839882-23-007052
Filing Date
2023-03-17
Accepted
2023-03-17 17:12:47
Documents
7
Period of Report
2023-05-05

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT tnxp-def14a_050523.htm DEF 14A 924777
2 GRAPHIC proxycard001.jpg GRAPHIC 1221
3 GRAPHIC proxycard002.jpg GRAPHIC 4801
4 GRAPHIC proxycard003.jpg GRAPHIC 3382
5 GRAPHIC proxycard004.jpg GRAPHIC 4976
6 GRAPHIC tnxpdef14a001.jpg GRAPHIC 53355
7 GRAPHIC tnxpdef14a002.jpg GRAPHIC 49396
  Complete submission text file 0001839882-23-007052.txt   1088037
Mailing Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928
Business Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928 212-980-9155
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36019 | Film No.: 23743759
SIC: 2834 Pharmaceutical Preparations